EX-23.1 2 d426596dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-265832, 333-254705, 333-236229, 333-232106, 333-226701, and 333-218468) and Form S-3 (No. 333-257640) of G1 Therapeutics, Inc. of our report dated March 1, 2023 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
March 1, 2023